Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia

BackgroundPost-transplant relapse remains a principal leading cause of failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with adult acute lymphoblastic leukemia (ALL). The aim of this study was to investigate the efficacy and safety of low-dose decitabine on th...

Full description

Bibliographic Details
Main Authors: Jia Liu, Zhong-Xing Jiang, Xin-Sheng Xie, Ding-Ming Wan, Wei-Jie Cao, Meng Wang, Zhen-Zhen Liu, Zhen-Kun Dong, Hai-Qiong Wang, Run-Qing Lu, Yin-Yin Zhang, Qian-Qian Cheng, Ji-Xin Fan, Wei Li, Fei He, Rong Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
allogeneic hematopoietic stem cell transplantation
decitabine
maintenance
prophylaxis
relapse
acute lymphoblastic leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.710545/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.710545/full

Similar Items